Société Générale gets a cash infusion

Société Générale (SG) is the latest of several banks to raise money through the capital markets after suffering multibillion-dollar losses. Unlike several Wall Street banks issuing mandatory convertibles, the French bank will sell stock and give current shareholders a preferential subscription right or the first right of refusal.

Current shareholders can buy SG stock at €47.5 a share, an amount much below the market price, and will receive one share for every four existing shares. However, they will not be allowed to sell the stock for 180 days. The bank expects to raise €5.5 billion by the time the subscription period ends on February 29.

"This is a quick way to raise money. It forces shareholders to buy stock unless they want to be left with a diluted share. It will be interesting to see if all the stockholders

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@risk.net or view our subscription options here: http://subscriptions.risk.net/subscribe

You are currently unable to copy this content. Please contact info@risk.net to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Risk.net? View our subscription options

Most read articles loading...

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here